(Q35983226)

11 August 2017

Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma (English)

1 reference

11 August 2017

2

D Cunningham

1 reference

11 August 2017

3

N Gilchrist

1 reference

11 August 2017

V Raina

1

1 reference

PMCID

1971849

11 August 2017

M Soukop

series ordinal

4

1 reference

PMCID

1971849

11 August 2017

language of work or name

English

0 references

publication date

1 March 1991

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

63

1 reference

11 August 2017

463-465

1 reference

11 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1991.108

11 August 2017

0 references

cites work

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971849

1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971849

Association between the expression of the c-myc oncogene mRNA and the expression of the receptor protein for 1,25-dihydroxyvitamin D3.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971849

Alfacalcidol as a modulator of growth of low grade non-Hodgkin's lymphomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971849

Receptor-mediated rapid action of 1 alpha,25-dihydroxycholecalciferol: increase of intracellular cGMP in human skin fibroblasts

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971849

Spontaneous regression of hematologic cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971849

Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971849

1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines

24 September 2018

1 reference

12 December 2020

1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone

1 reference

12 December 2020

The natural history of initially untreated low-grade non-Hodgkin's lymphomas

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20)

1 reference

12 December 2020

Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3

1 reference

12 December 2020

Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification

1 reference

12 December 2020

Non-Hodgkin's lymphoma: Patterns of relapse from complete remission after combination chemotherapy

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3Receptors in Human Leukocytes

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1991.108

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

PMCID

1971849